Judge Questions Difference Between Pete Hegseth’s Policy on Testosterone and Medical Care for Transgender Soldiers

Judge Questions Difference Between Pete Hegseth’s Policy on Testosterone and Medical Care for Transgender Soldiers

Washington – Defense Secretary Pete Hegseth’s new initiative to test and treat soldiers with low testosterone levels has led a federal judge to question the differences between that type of testosterone replacement therapy and hormone treatment for transgender men in the military.

U.S. District Judge Ana Reyes of Washington raised the issue Wednesday in an ongoing lawsuit against President Donald Trump’s ban on transgender soldiers serving in the Armed Forces. Reyes noted that Trump’s ban states that “the Armed Forces must meet high standards of mental and physical health… without being able to benefit from routine medical treatments or special provisions.”

Reyes ordered both sides in the litigation to address “the similarities and differences in the administration of TRT, both medically and logistically, for trans men compared to other members of the Armed Forces, including cis people.” He used the acronym TRT for “testosterone replacement therapy.”

Kumneger Media
Kumneger Media
Kumneger Media is a News and Entertainment Website & Channel. Kumneger Media in addition to News and Entertainment it is the hub of Politics, Movies, Drama, Music, Comedy, Documentary and More!